Teva Kicks Off Trial To Revoke Bayer's Cancer Drug Patent
Generic-drug maker Teva opened a London trial Tuesday by telling the judge that its bid to revoke three patents for Bayer's liver and kidney cancer drug had been significantly narrowed to...To view the full article, register now.
Already a subscriber? Click here to view full article